Literature DB >> 32671659

The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies.

Qiu Xu1, Qiu-Xiang Li1, Fang-Fang Bi1, Hui-Qian Duan1, Yue-Bei Luo2, Huan Yang3.   

Abstract

OBJECTIVE: To investigate specific muscle pathologies of different kinds of myositis-specific autoantibodies (MSAs) in idiopathic inflammatory myopathy (IIM) patients.
METHODS: One hundred eleven Chinese patients from Xiangya Hospital, Central South University diagnosed with IIMs according to European Neuromuscular Centre (ENMC) criteria were included. Clinical manifestation, myositis-specific autoantibodies, and histologic findings were evaluated to explore the pattern of necrosis, regeneration, and perifascicular atrophy, inflammatory cells in IIM patients with different MSAs.
RESULTS: Anti-SRP group has the lowest muscle strength scores, the highest creatine kinase levels, the most severe degree of necrosis and regeneration (1.90[0.80-3.95], 1.00[0.30-1.71]), and the lowest positive rate of MHC-I staining (35.71%). The anti-MDA5 group demonstrates the mildest pathological changes, with the fewest necrotic and regenerated muscle fibers (0.00[0.00-0.50], 0.00[0.00-0.00]), and the fewest inflammatory cell infiltration, and the highest muscle strength scores. The anti-NXP2 group has the most frequent inflammatory infiltrates, especially CD4+ T cells (31.14[15.00-39.00]). The patients with anti-NXP2 and the anti-TIF1γ antibodies show higher frequency of punched-out fibers (1.50[0.00-3.70], 0.00[0.00-1.00]) and perifascicular atrophy (71.43%, 55.56%). As for anti-synthetase antibodies (ASAs), the anti-Jo-1 group shows the most frequent rate of perifascicular necrosis (60%), while other ASA groups do not show perifascicular necrosis.
CONCLUSIONS: Of the MSAs, the anti-SRP antibody leads to the most severe muscle involvement, while the anti-MAD5 antibody the mildest. The anti-NXP2 and anti-TIF1γ groups have the most typical "DM" pathology. Key Points • Anti-SRP group shows severe muscle pathology while anti-MDA5 group shows the mildest. • Anti-NXP2 group has the most frequent inflammatory infiltrates. Pouch-out fibers and perifascicular atrophy are more prevalent in anti-NXP2 and anti-TIF1γ groups. • Anti-Jo-1 group is often accompanied by perifascicular necrosis, while other anti-synthetase antibody groups are not.

Entities:  

Keywords:  Idiopathic inflammatory myopathies; Inflammation; Myopathology; Myositis-specific autoantibodies

Mesh:

Substances:

Year:  2020        PMID: 32671659     DOI: 10.1007/s10067-020-05274-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  32 in total

1.  Description of a serological reaction characteristic of polymyositis.

Authors:  M Reichlin; M Mattioli
Journal:  Clin Immunol Immunopathol       Date:  1976-01

Review 2.  Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.

Authors:  Levente Bodoki; Melinda Nagy-Vincze; Zoltán Griger; Zoe Betteridge; Lászlóné Szöllősi; Katalin Dankó
Journal:  Autoimmun Rev       Date:  2014-08-23       Impact factor: 9.754

Review 3.  Dermatomyositis, polymyositis and immune-mediated necrotising myopathies.

Authors:  Yue-Bei Luo; Frank L Mastaglia
Journal:  Biochim Biophys Acta       Date:  2014-06-05

4.  Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.

Authors:  Lénaig Mescam-Mancini; Yves Allenbach; Baptiste Hervier; Hervé Devilliers; Kuberaka Mariampillay; Odile Dubourg; Thierry Maisonobe; Romain Gherardi; Paulette Mezin; Corinna Preusse; Werner Stenzel; Olivier Benveniste
Journal:  Brain       Date:  2015-07-21       Impact factor: 13.501

5.  Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.

Authors:  Puja Srivastava; Sanjay Dwivedi; Ramnath Misra
Journal:  Rheumatol Int       Date:  2016-05-14       Impact factor: 2.631

6.  Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients.

Authors:  Yoshinao Muro; Kazumitsu Sugiura; Masashi Akiyama
Journal:  Autoimmunity       Date:  2013-02-08       Impact factor: 2.815

Review 7.  The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.

Authors:  L G Rider; K Nistala
Journal:  J Intern Med       Date:  2016-03-30       Impact factor: 8.989

8.  Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.

Authors:  Hanbo Yang; Qinglin Peng; Liguo Yin; Shanshan Li; Jingli Shi; Yamei Zhang; Xin Lu; Xiaoming Shu; Sigong Zhang; Guochun Wang
Journal:  Arthritis Res Ther       Date:  2017-11-25       Impact factor: 5.156

9.  Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.

Authors:  Z Betteridge; S Tansley; G Shaddick; H Chinoy; R G Cooper; R P New; J B Lilleker; J Vencovsky; L Chazarain; K Danko; M Nagy-Vincze; L Bodoki; M Dastmalchi; L Ekholm; I E Lundberg; N McHugh
Journal:  J Autoimmun       Date:  2019-04-13       Impact factor: 7.094

Review 10.  Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.

Authors:  Z Betteridge; N McHugh
Journal:  J Intern Med       Date:  2015-11-25       Impact factor: 8.989

View more
  1 in total

1.  Profile of specific and associated autoantibodies in patients with idiopathic inflammatory myopathies in a Colombian population.

Authors:  Andrés Hormaza-Jaramillo; Vanessa Bedoya-Joaqui; Germán Puerta-Sarmiento; Mario Bautista; Lady J Rios-Serna; Tatiana Delgado-Mora; Ivana Nieto-Aristizábal; Ingrid Ruiz-Ordoñez
Journal:  Front Med (Lausanne)       Date:  2022-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.